RBP4 and metabolic dysfunction-associated steatotic liver disease: As shown in Fig. 3, the NAFLD patients who were diagnosed by ultrasound techniques had significantly increased RBP4 levels compared with healthy controls (SMD: 0.45; 95% CI: 0.20, 0.71; P = 0.001).